Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers
Rebeca Lozano, Elena Castro, Fernando López‐Campos, Heather Thorne, M. Backhaus, Isabel M. Aragón, Ylenia Cendón, Ana Gutiérrez-Pecharromán, Daniela C. Salles, Nuria Romero-Laorden, David Lorente, Pilar Gónzalez‐Peramato, Ana Calatrava, Concepción Alonso, Urbano Anido, Sara Arévalo-Lobera, Judith Balmañà, Isabel Chirivella, María José Juan-Fita, Gemma Llort, Teresa Ramón y Cajal, Elena Almagro, Daniel Alameda, Pedro P. López‐Casas, Bernardo Herrera, Joaquı́n Mateo, Colin C. Pritchard, Emmanuel S. Antonarakis, Tamara L. Lotan, J. Rubio‐Briones, Shahneen Sandhu, David Olmos (2023). Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers. , 185, DOI: https://doi.org/10.1016/j.ejca.2023.02.022.
Article155 days agoValue of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
Rebeca Lozano, David Lorente, Isabel M. Aragón, Nuria Romero-Laorden, Paz Nombela, Joaquı́n Mateo, Alison Reid, Ylenia Cendón, Diletta Bianchini, Casilda Llácer, Shahneen Sandhu, Adam Sharp, Pasquale Rescigno, Teresa Garcés, M.I. Pacheco, Penelope Flohr, Christophe Massard, Pedro P. López‐Casas, Elena Castro, Johann S. de Bono, David Olmos (2021). Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients. , 13(10), DOI: https://doi.org/10.3390/cancers13102334.
Article155 days agoCirculating tumour cells (CTC) count and prostate-specific antigen (PSA) response measures in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with docetaxel (Doc)
Shahneen Sandhu, Nuria Romero-Laorden, Ylenia Cendón, Adam Sharp, Enrique de Álava, M.I. Pacheco, Pasquale Rescigno, Casilda Llácer, M.I. Sáez, L. Rivera, Francesca Vitrone, C Puivecino Moreno, Joaquı́n Mateo, Johann S. de Bono, David Olmos, R. Lozano Mejorada, David Lorente, Elena Castro, Diletta Bianchini, Paz Nombela (2019). Circulating tumour cells (CTC) count and prostate-specific antigen (PSA) response measures in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with docetaxel (Doc). , 30, DOI: https://doi.org/10.1093/annonc/mdz248.046.
Article155 days ago